MedTrace Logo

Innovative Digital Therapeutic for Smoking Cessation

NCT03694327 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 158

Last updated 2022-06-06

Study results available
· View outcomes & findings →

Summary

This study is comparing the efficacy of two smoking cessation apps.

Conditions

  • Smoking Cessation
  • Nicotine Addiction
  • Drug Addiction
  • Drug Dependence
  • Tobacco Dependence
  • Tobacco Use Disorder
  • Substance Use Disorder
  • Tobacco Smoking

Interventions

DEVICE

CT-101-M

Mobile Application

DEVICE

QuitGuide

Mobile Application

Sponsors & Collaborators

  • My Digital Study

    lead INDUSTRY

Principal Investigators

  • Brian M Iacoviello, PhD · My Digital Study

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-24
Primary Completion
2019-03-14
Completion
2019-03-14
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03694327 on ClinicalTrials.gov